Robert Oldham
Medical Oncology · Crestview, FLNPI 1548255334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $483 and has fallen 82.4% since, to $85 in 2022. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 71 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$184
- E.r. Squibb & Sons, L.L.C.$114
- Merck$111
- AstraZeneca$82
- Genentech USA, Inc.$77
- Amgen$68
- plus $494 from 20 others
What the payments were for
- Food & beverage$1,09397%
- Education$383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 11 | $184 |
| E.r. Squibb & Sons, L.L.C. | 9 | $114 |
| Merck | 7 | $111 |
| AstraZeneca | 6 | $82 |
| Genentech USA, Inc. | 5 | $77 |
| Amgen | 4 | $68 |
| Johnson & Johnson | 3 | $49 |
| AbbVie | 2 | $46 |
| Eisai Inc. | 2 | $40 |
| Genentech, Inc. | 1 | $38 |
| Rigel Pharmaceuticals, Inc. | 2 | $34 |
| Sanofi | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $28 |
| Pfizer | 2 | $25 |
| Bayer | 1 | $24 |
| Beigene USA, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $15 |
| Coherus Oncology, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $13 |
| Deciphera Pharmaceuticals Inc. | 1 | $11 |
| Ipsen Biopharmaceuticals, Inc | 1 | $11 |
How this compares
$1,131 in reported general payments places this provider in the 15th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Crestview
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.